Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
27.12.2018 22:14:00

Cardiac Valve Repair Devices (Cardiovascular Devices) - Global Market Analysis and Forecast Model

LONDON, Dec. 27, 2018 /PRNewswire/ -- Cardiac Valve Repair Devices (Cardiovascular Devices) - Global Market Analysis and Forecast Model

Download the full report:

Summary
Cardiac Valve Repair Devices (Cardiovascular Devices) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

Mitral regurgitation is more widespread than aortic valve disease and requires effective treatment options.Mitral valve repair is the preferred treatment option for mitral regurgitation and valve replacement is recommended only for cases where repair will not have any impact.

Cardiac valve repair devices are used in the repair of malfunctioning valves.Only mitral valve repair has been covered under this segment.

Tricuspid and Aortic annuloplasty rings are not included here.Annuloplasty is a technique used to repair an enlarged annulus, a ring is placed at the base of the heart valve.

This annuloplasty ring makes the opening of valve smaller, providing more support and a tighter closure of the valve.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes.To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available).

Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model

Currently marketed cardiac valve repairs and evolving competitive landscape -
- Insightful review of the key industry trends.
- Annualized total cardiac valve repairs market revenue by segment and market outlooks from 2015-2028.
- Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
- SWOT analysis for Cardiac Valve Repair Devices market.
- Competitive dynamics insights and trends provided for Cardiac Valve Repair Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market.Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders.

In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Medtronic plc, Edwards Lifesciences Corp, Abbott Laboratories, LivaNova PLC, Braile Biomedica Ltda, Labcor Laboratories Ltda., Genesee BioMedical, Inc., Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope
This Market Model gives important, expert insight you won't find in any other source.

The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
- CMO executives who must have deep understanding of the cardiac valve repairs marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to buy
The model will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving cardiac valve repairs market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the cardiac valve repairs market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific cardiac valve repairs market from 2015-2028.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Download the full report:

About
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email:
Tel: +1 (718) 213 4904
Website:

Cision View original content:

SOURCE ReportBuyer

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!